MENU
Lantern Pharma (LTRN) Ownership - Who owns Lantern Pharma?
Profile
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
37.25M
P/E Ratio
N/A
Total Cash
33.26M
Projected Growth
N/A
Total Debt
218.7K
Revenue
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash/Share
3.09
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
LTRN
Capitalization
37.2M
P/E Ratio
N/A
Risk (Beta)
1.60
Dividend Yield
N/A
Total Cash
33.3M
Total Cash/Share
3.09
Total Debt
219K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
30.9M
P/B Ratio
1.20
Cash Flow
N/A
Earnings
-1.65
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.08K
Current Ratio
7.67
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-19.53M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-40.79
Shares Held By Institutions
9.22M
Shares Outstanding - Current
10.8M
Total Liabilities
4.66M
Total Volume MTD
N/A
Value
1
Gain YTD
-19.159
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1920 McKinney Avenue
Phone
+1 972 277-1136
Employees
21
Web
https://www.lanternpharma.com